annual cash & cash equivalents:
$890.06M+$372.27M(+71.90%)Summary
- As of today (September 9, 2025), GMED annual cash & cash equivalents is $890.06 million, with the most recent change of +$372.27 million (+71.90%) on December 31, 2024.
- During the last 3 years, GMED annual cash & cash equivalents has risen by +$446.61 million (+100.71%).
- GMED annual cash & cash equivalents is now at all-time high.
Performance
GMED Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$229.45M-$231.82M(-50.26%)Summary
- As of today (September 9, 2025), GMED quarterly cash & cash equivalents is $229.45 million, with the most recent change of -$231.82 million (-50.26%) on June 30, 2025.
- Over the past year, GMED quarterly cash & cash equivalents has dropped by -$263.49 million (-53.45%).
- GMED quarterly cash & cash equivalents is now -74.22% below its all-time high of $890.06 million, reached on December 31, 2024.
Performance
GMED quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GMED Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +71.9% | -53.5% |
| 3 y3 years | +100.7% | -43.8% |
| 5 y5 years | +185.7% | -27.6% |
GMED Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.7% | -74.2% | at low |
| 5 y | 5-year | at high | +185.7% | -74.2% | at low |
| alltime | all time | at high | +696.8% | -74.2% | +60.8% |
GMED Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $229.45M(-50.3%) |
| Mar 2025 | - | $461.27M(-48.2%) |
| Dec 2024 | $890.06M(+71.9%) | $890.06M(+28.1%) |
| Sep 2024 | - | $694.71M(+40.9%) |
| Jun 2024 | - | $492.93M(+13.5%) |
| Mar 2024 | - | $434.47M(-16.1%) |
| Dec 2023 | $517.79M(+16.1%) | $517.79M(+10.4%) |
| Sep 2023 | - | $468.93M(-23.5%) |
| Jun 2023 | - | $612.83M(+21.5%) |
| Mar 2023 | - | $504.37M(+13.1%) |
| Dec 2022 | $446.06M(+0.6%) | $446.06M(+10.1%) |
| Sep 2022 | - | $405.29M(-0.7%) |
| Jun 2022 | - | $408.01M(-13.8%) |
| Mar 2022 | - | $473.29M(+6.7%) |
| Dec 2021 | $443.45M(+3.9%) | $443.45M(-19.8%) |
| Sep 2021 | - | $553.20M(+20.1%) |
| Jun 2021 | - | $460.43M(+14.1%) |
| Mar 2021 | - | $403.56M(-5.4%) |
| Dec 2020 | $426.74M(+37.0%) | $426.74M(+4.2%) |
| Sep 2020 | - | $409.64M(+29.3%) |
| Jun 2020 | - | $316.74M(+14.4%) |
| Mar 2020 | - | $276.95M(-11.1%) |
| Dec 2019 | $311.49M(-8.3%) | $311.49M(+12.2%) |
| Sep 2019 | - | $277.59M(+15.5%) |
| Jun 2019 | - | $240.43M(-25.0%) |
| Mar 2019 | - | $320.66M(-5.6%) |
| Dec 2018 | $339.68M | $339.68M(-8.9%) |
| Sep 2018 | - | $372.76M(+3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $360.92M(-2.2%) |
| Mar 2018 | - | $369.18M(-1.2%) |
| Dec 2017 | $373.71M(+28.5%) | $373.71M(+10.7%) |
| Sep 2017 | - | $337.66M(+8.0%) |
| Jun 2017 | - | $312.67M(-4.3%) |
| Mar 2017 | - | $326.57M(+12.3%) |
| Dec 2016 | $290.79M(-5.3%) | $290.79M(+12.5%) |
| Sep 2016 | - | $258.40M(-23.0%) |
| Jun 2016 | - | $335.75M(+2.2%) |
| Mar 2016 | - | $328.58M(+7.0%) |
| Dec 2015 | $307.15M(+21.8%) | $307.15M(+16.3%) |
| Sep 2015 | - | $263.99M(+17.6%) |
| Jun 2015 | - | $224.49M(-5.1%) |
| Mar 2015 | - | $236.65M(-6.1%) |
| Dec 2014 | $252.07M(+5.5%) | $252.07M(-15.6%) |
| Sep 2014 | - | $298.75M(+8.1%) |
| Jun 2014 | - | $276.26M(-1.6%) |
| Mar 2014 | - | $280.81M(+17.5%) |
| Dec 2013 | $238.92M(+12.5%) | $238.92M(+12.1%) |
| Sep 2013 | - | $213.15M(+32.3%) |
| Jun 2013 | - | $161.16M(-0.7%) |
| Mar 2013 | - | $162.33M(-23.6%) |
| Dec 2012 | $212.40M(+48.9%) | $212.40M(+8.8%) |
| Sep 2012 | - | $195.16M(+17.9%) |
| Jun 2012 | - | $165.58M(+4.1%) |
| Mar 2012 | - | $159.10M(+11.5%) |
| Dec 2011 | $142.67M(+27.7%) | $142.67M |
| Dec 2010 | $111.70M | - |
FAQ
- What is Globus Medical, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Globus Medical, Inc.?
- What is Globus Medical, Inc. annual cash & cash equivalents year-on-year change?
- What is Globus Medical, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Globus Medical, Inc.?
- What is Globus Medical, Inc. quarterly cash & cash equivalents year-on-year change?
What is Globus Medical, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of GMED is $890.06M
What is the all time high annual cash & cash equivalents for Globus Medical, Inc.?
Globus Medical, Inc. all-time high annual cash & cash equivalents is $890.06M
What is Globus Medical, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, GMED annual cash & cash equivalents has changed by +$372.27M (+71.90%)
What is Globus Medical, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GMED is $229.45M
What is the all time high quarterly cash & cash equivalents for Globus Medical, Inc.?
Globus Medical, Inc. all-time high quarterly cash & cash equivalents is $890.06M
What is Globus Medical, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, GMED quarterly cash & cash equivalents has changed by -$263.49M (-53.45%)